Seroprevalence of antibody to S1 spike protein following vaccination against COVID-19 in patients receiving hemodialysis: a call to arms
Roseanne E Billany, Haresh Selvaskandan, Sherna Adenwalla, Katherine L. Hull, Daniel S. March, James O. Burton, Nicolette C. Bishop, Edward J Carr, Rupert Beale, Julian W. Tang, Paul Bird, Christopher W. Holmes, Richard Baines, Nigel J. Brunskill, Matthew Graham‐Brown
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Spike ProteinSeroprevalenceVirologyMedicineSpike (software development)2019-20 coronavirus outbreakVaccinationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)AntibodyHemodialysisOutbreakCoronavirusBetacoronavirusImmunologySerologyInternal medicineInfectious disease (medical specialty)Computer scienceDiseaseSoftware engineeringSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19